Evidence map›Paper›PMID 42370762›Full record

ArticleCell biology international2026

Impaired Neurosphere Formation as a Functional Readout of Aberrant EGFR Signaling Kinetics in Olfactory Neural Progenitors From Patients With Schizophrenia.

Tommaso Toffanin, Mario Angelo Pagano, Carlo Idotta, Mauro Salvi, Valentina Bosello-Travain, Maria Lina Massimino, Roberto Saetti, Marina Silvestrini, Leonardo Meneghetti, Stefano Piazza and 8 more

Abstract read
In one paragraph

Article in Cell biology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Tommaso ToffaninDepartment of Neuroscience and Rehabilitation, Institute of Psychiatry, University of Ferrara, Ferrara, Italy.
Mario Angelo PaganoDepartment of Neuroscience and Rehabilitation, Institute of Psychiatry, University of Ferrara, Ferrara, Italy.ORCID https://orcid.org/0000-0003-4186-7658
Carlo IdottaMetis ETS, San Martino di Lupari, Italy.
Mauro SalviDepartment of Biomedical Sciences, University of Padova, Padova, Italy.
Valentina Bosello-TravainDepartment of Molecular Medicine, University of Padova, Padova, Italy.
Maria Lina MassiminoNeuroscience Institute, Section of Padova, National Research Council (CNR), Padova, Italy.
Roberto SaettiDepartment of Otolaryngology, San Bortolo Hospital, Vicenza, Italy.
Marina SilvestriniDepartment of Otolaryngology, San Bortolo Hospital, Vicenza, Italy.
Leonardo MeneghettiDepartment of Mental Health, Vicenza, Italy.
Stefano PiazzaDepartment of Mental Health, Vicenza, Italy.
Maria Giulia NanniDepartment of Neuroscience and Rehabilitation, Institute of Psychiatry, University of Ferrara, Ferrara, Italy.
Rosangela CarusoDepartment of Neuroscience and Rehabilitation, Institute of Psychiatry, University of Ferrara, Ferrara, Italy.
Maria FerraraDepartment of Neuroscience and Rehabilitation, Institute of Psychiatry, University of Ferrara, Ferrara, Italy.
Chiara MontemitroDepartment of Neuroscience and Rehabilitation, Institute of Psychiatry, University of Ferrara, Ferrara, Italy.ORCID https://orcid.org/0000-0002-3280-1895
Luigi ZerbinatiDepartment of Neuroscience and Rehabilitation, Institute of Psychiatry, University of Ferrara, Ferrara, Italy.
Martino Belvederi MurriDepartment of Neuroscience and Rehabilitation, Institute of Psychiatry, University of Ferrara, Ferrara, Italy.
Luigi GrassiDepartment of Neuroscience and Rehabilitation, Institute of Psychiatry, University of Ferrara, Ferrara, Italy.ORCID https://orcid.org/0000-0002-1050-4494
Anna Maria BrunatiDepartment of Molecular Medicine, University of Padova, Padova, Italy.

Funding

#NEXTGENERATIONEU (NGEU) and funded by the Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP), project MNESYS (PE0000006) - A Multiscale integrated approach to the study of the nervous system in health and disease 1553 11.10.2022
6 · The paper itself

Abstract

The Epidermal Growth Factor Receptor (EGFR) is a key regulator of neurodevelopment, controlling the proliferation, differentiation, and self-renewal of neural stem and progenitor cells. Dysregulated EGFR signaling has been implicated in schizophrenia, a neurodevelopmental disorder associated with abnormal cortical maturation. We investigated EGFR-dependent signaling in neural stem/progenitor cells derived from olfactory neuroepithelium (hereafter referred to as Olfactory Neural Stem/Progenitor Cells, ONSPCs) collected from individuals with no prior history of psychiatric disorders (hereafter referred to as healthy controls, HC) and patients diagnosed with schizophrenia (schizophrenic, SZ), an ex vivo human model that retains disease-related molecular signatures. Both HC- and SZ-derived ONSPCs formed neurospheres under proliferative conditions in the presence of the growth factors Epidermal Growth Factor (EGF) and Fibroblast Growth Factor (FGF), confirming their neural progenitor identity. However, under EGF-exclusive conditions, HC-derived ONSPCs generated compact, well-organized neurospheres, whereas SZ-derived ONSPCs produced sparse, irregular aggregates, indicating impaired responsiveness to EGF. Despite comparable EGFR protein levels between groups, EGF stimulation revealed distinct dynamics of downstream EGFR effectors. In HC-derived ONSPCs, EGFR activation was initially modest but sustained over time, whereas in SZ-derived cells it was more rapid and transiently stronger, followed by early signal decay. In particular, Akt and Src, which are implicated in signaling pathways driving proliferation and self-renewal, displayed activation dynamics paralleling those of EGFR in each group. These findings are consistent with dysregulation of the magnitude and temporal dynamics of EGFR-dependent signaling in SZ-derived ONSPCs, associated with impaired neurosphere formation under EGF-exclusive conditions and suggestive of reduced self-renewal capacity. Although limited by the modest sample size, the semiquantitative nature of Western blot analyses, and the potential effect of medication exposure, this study supports the relevance of patient-derived ONSPCs as a physiologically meaningful platform for investigating neurodevelopmental mechanisms underlying schizophrenia.

Indexed as

ErbB ReceptorsNeural Stem CellsSchizophreniaAdultCell DifferentiationCell ProliferationCells, CulturedEpidermal Growth FactorFemaleHumansKineticsMaleNeurodevelopmentOlfactory MucosaSignal TransductionEGFR protein, humanEpidermal Growth FactorErbB Receptorsepidermal growth factor receptorneurospheresolfactory neuroepitheliumschizophrenia

Identifiers

PMID42370762
PMCPMC13312894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.